Skip to main content

Month: September 2025

Sonnet to Present at the MedInvest Biotech & Pharma Conference

Live webcast presentation on Thursday, September 25th at 9:40 AM PT PRINCETON, N.J., Sept. 19, 2025 (GLOBE NEWSWIRE) — Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) (the “Company” or “Sonnet”), a clinical-stage company developing immunotherapeutic drugs targeted to the tumor microenvironment (TME), today announced that Raghu Rao, Interim Chief Executive Officer of Sonnet, will present on Thursday, September 25, 2025 at 9:40 AM PT at the MedInvest Biotech & Pharma Conference being held in Palo Alto, California. In addition to the presentation, management will be available to participate in one-on-one meetings with qualified members of the investor community who are registered to attend the conference. For more information, please visit the conference website. A live webcast of the presentation...

Continue reading

ZOOZ Shareholders Approve Previously Announced $180 Million Private Placement and Bitcoin Treasury Reserve Strategy, Along with All Related Proposals

Approval positions ZOOZ to become the first Nasdaq and TASE dual-listed company to hold Bitcoin in its treasury  TEL AVIV, Israel, Sept. 19, 2025 (GLOBE NEWSWIRE) — ZOOZ Power Ltd. (Nasdaq and TASE: ZOOZ) (“ZOOZ” or the “Company”) today announced that at its Extraordinary General Meeting, shareholders voted to approve all proposals related to the Company’s previously announced $180 million private placement (the “PIPE”) and Bitcoin Treasury Reserve Strategy. Following this approval, ZOOZ expects to close the PIPE during the week of September 22, 2025, subject to customary closing conditions and final documentation. Key Proposals ApprovedIssuance of Ordinary Shares and Warrants in connection with the $180 million PIPE, including $5 million sold in the initial private placement Amendment to the Company’s Articles of Association...

Continue reading

MT Højgaard Holding A/S: Enemærke & Petersen to construct new building at Sluseholmen

MT Højgaard Holding’s business unit Enemærke & Petersen has, through the ByK & TRUST partnership, entered into an agreement to design and construct a new building at Sluseholmen in the South Harbour district in Copenhagen. The agreement covers a turnkey contract with a total value of DKK 263 million with workstreams commencing in September 2025 and expected completion in April 2028. The contract has been entered into with the developer unit of the City of Copenhagen, Byggeri København (ByK), on behalf of the Social Services Administration. The project is comprised of a 5-storey building with floor area of 8,500 square meters including basement. Approximately 7,000 square meters will house a social residential facility while the remaining space will be laid out for business, technical installations and basement. The 24-hour residential...

Continue reading

Composition of the Nomination Board of Siili Solutions Plc

Composition of the Nomination Board of Siili Solutions Plc Siili Solutions Plc Stock exchange release 19 September 2025 at 16:15 EEST The Shareholders’ Nomination Board of Siili Solutions Plc consists of five (5) members, of whom the company’s four (4) largest shareholders are each entitled to nominate one. The Chair of the Board of Directors serves as the fifth member of the Board in the role of an expert.  The duties of the Shareholders’ Nomination Board include, among other things, the preparation of proposals to the Annual General Meeting, or where necessary, an Extraordinary General Meeting, on the number of directors, the candidates as well as their remuneration. In accordance with the above, the members of Siili’s Shareholders’ Nomination Board are: Heikki Westerlund, representative of Lamy Ltd  Stian Runde, Protector Forsikring Ville...

Continue reading

Signature HealthCARE Committed to Proactive Resident Safety with SafeSpace Global Corporation

Knoxville, TN, Sept. 19, 2025 (GLOBE NEWSWIRE) — SafeSpace Global Corporation (OTCID:SSGC), a global leader in multimodal AI technology, is pleased to announce an expanded partnership with Signature HealthCARE. Signature HealthCARE, a family-based healthcare company known for delivering integrated care across multiple states and advancing person-directed care, enhanced its commitment to proactive resident safety through its partnership with SafeSpace Global Corporation. This agreement, effective September 19, 2025, is designed to expand care capacity for residents, support staff in a labor-challenged market, and strengthen safety systems across communities. Signature HealthCARE offers a continuum of specialty care in skilled nursing, rehabilitation, assisted living, and memory healthcare. Guided by its core pillars of learning,...

Continue reading

Heritage Distilling Announces Ticker Symbol Change to “IPST”

GIG HARBOR, Wash., Sept. 19, 2025 (GLOBE NEWSWIRE) — Heritage Distilling Holding Company, Inc. (Nasdaq: CASK) (the “Company”) today announced that it will change its ticker symbol on the Nasdaq Capital Market (“Nasdaq”) from “CASK” to “IPST”, effective at the opening of trading on Monday September 22, 2025. The CUSIP number for the Company’s common stock will remain unchanged. The new ticker reflects the Company’s strategic focus on its $IP token treasury strategy and the $80 trillion intellectual property economy. No action is required by current stockholders. Shares of the Company’s common stock will continue to be listed and traded on Nasdaq. Additional details regarding the Company’s strategy and results of its recent Special Meeting of Stockholders will be provided in a separate press release expected to be issued on Monday...

Continue reading

InterCure Announces Strategic Acquisition of ISHI, Unlocking Access to Premium U.S. Cannabis Technology and Brands

Acquisition of leading cannabis company marks major milestone in InterCure’s commercial expansion strategy, bringing access to premium American brands and state-of-the-art cultivation technologies Transaction comes as Trump administration confirms it is exploring cannabis rescheduling, creating unprecedented potential opportunities for international operators like InterCure InterCure encouraged by recent regulatory momentum and positioned to capitalize on evolving U.S. cannabis landscape NEW YORK & HERZLIYA, Israel, Sept. 19, 2025 (GLOBE NEWSWIRE) — InterCure Ltd. (Nasdaq: INCR) (TASE: INCR) (“InterCure” or the “Company“) today announced the strategic acquisition of Botanico Ltd., also known as ISHI (“ISHI“), a premium medical cannabis technology and brand company that delivers immediate...

Continue reading

Nexxen Launches New $20 Million Ordinary Share Repurchase Program

NEW YORK, Sept. 19, 2025 (GLOBE NEWSWIRE) — Nexxen International Ltd. (NASDAQ: NEXN) (“Nexxen” or the “Company”), a global, flexible advertising technology platform with deep expertise in data and advanced TV, today announced the launch of a new $20 million Ordinary Share repurchase program (the “new repurchase program”), following the end of the creditor objection period, as announced by the Company on August 15, 2025. Nexxen has completed its previous $50 million Ordinary Share repurchase program and the new repurchase program is expected to continue until the earlier of March 19, 2026, or completion. The new repurchase program does not obligate Nexxen to repurchase any particular amount of Ordinary Shares and the program may be suspended, modified, or discontinued at any time at the Company’s discretion, subject to applicable...

Continue reading

Jushi Holdings Inc. Announces Grand Opening of Beyond Hello™ Parma in Ohio, Expanding its Statewide Retail Footprint

Sixth Beyond Hello Location in Ohio and 41st Retail Location Nationwide New Dispensary Opens September 19th in Parma, Just South of Cleveland Grand Opening Celebration with Exclusive Promotions September 19 – October 4, 2025A Media Snippet accompanying this announcement is available by clicking on this link. BOCA RATON, Fla., Sept. 19, 2025 (GLOBE NEWSWIRE) — Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH) (OTCQX: JUSHF), a vertically integrated, multi-state cannabis operator, today announced the grand opening of its Beyond Hello™ Parma dispensary located at 6891 Ridge Rd, Parma, OH 44129. Beyond Hello Parma marks the Company’s 6th store in the state of Ohio joining Cincinnati, Toledo, Oxford, Warren and Mansfield, and the 41st operating retail location nationwide.The new dispensary will officially open...

Continue reading

neffy® (epinephrine nasal spray) Approved in Japan as the First and Only Needle-Free Emergency Treatment of Allergic Reactions (anaphylaxis)

neffy 1 mg and 2 mg doses approved by Japanese regulators neffy offers a new delivery method for epinephrine in Japan for adults and children (>15 kg) living with severe allergic reactions Alfresa Holdings, which owns the rights to market neffy in Japan, expects availability in Q4 2025 SAN DIEGO, Sept. 19, 2025 (GLOBE NEWSWIRE) — ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and their caregivers to better protect themselves from allergic reactions that could lead to anaphylaxis, announced today that the Pharmaceuticals and Medical Devices Agency (PMDA), the Japanese authority responsible for the scientific review of drugs and medical devices, has granted approval for neffy® (epinephrine nasal spray) 1 mg and 2 mg doses, for the emergency treatment of allergic reactions...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.